Conference
Helicobacter pylori: A clinical update
Abstract
The aim of the study was to summarize the indications for H. pylori therapy and the optimum regimen to use. A review of the literature revealed that H. pylori eradication therapy is indicated in peptic ulcer disease, nonulcer dyspepsia and as part of an H. pylori test and treat strategy in uninvestigated dyspepsia. The optimum therapy to use was either a proton pump inhibitor (PPI) od, clarithromycin 250 mg bd, and metronidazole 400 mg bd (PCM) …
Authors
Moayyedi P; Murphy B
Volume
90
Publication Date
June 26, 2001
Conference proceedings
Journal of Applied Microbiology Symposium Supplement
Issue
30
ISSN
0267-4440